Neogenomics NEO
NASDAQ NEO
$16.73 +0.34 (+2.04%)
As of: Oct 23, 2026 · 3:15 PM EDT

Neogenomics (NEO) Liabilities from Discontinued Operations (2025)

Updated

Neogenomics (NEO) reported Liabilities from Discontinued Operations of $478,000 for Q3 2025, up 4.8% from the prior quarter.

Analysis

Neogenomics (NEO) Liabilities from Discontinued Operations (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 103.78 Bn 99.79 Bn -
2 Natera 58.29 Bn 53.97 Bn 485.19 Mn
3 Quest Diagnostics 27.12 Bn 25.25 Bn 1.03 Bn
4 Labcorp Holdings 27.05 Bn 24.80 Bn 1.11 Bn
5 Guardant Health 22.79 Bn 18.85 Bn 219.03 Mn
6 Tenet Healthcare 22.51 Bn 11.51 Bn -
7 Fresenius Medical Care AG 13.21 Bn 5.16 Bn 1.52 Bn
8 BrightSpring Health Services 12.41 Bn 10.74 Bn 492.75 Mn
9 Encompass Health 12.23 Bn 11.89 Bn -
10 Neogenomics 2.17 Bn 1.55 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 478,000.00
Jun 30, 2025 456,000.00
API Access

Neogenomics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=NEO&period=max&api_key=YOUR_API_KEY